Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapy.

Sweeney MO, van Bommel RJ, Schalij MJ, Borleffs CJ, Hellkamp AS, Bax JJ.

Circulation. 2010 Feb 9;121(5):626-34. doi: 10.1161/CIRCULATIONAHA.109.894774. Epub 2010 Jan 25.

2.

Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.

Hsing JM, Selzman KA, Leclercq C, Pires LA, McLaughlin MG, McRae SE, Peterson BJ, Zimetbaum PJ.

Circ Arrhythm Electrophysiol. 2011 Dec;4(6):851-7. doi: 10.1161/CIRCEP.111.962605. Epub 2011 Sep 28.

3.

QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy.

Sweeney MO, Hellkamp AS, van Bommel RJ, Schalij MJ, Borleffs CJ, Bax JJ.

Heart Rhythm. 2014 May;11(5):806-13. doi: 10.1016/j.hrthm.2014.01.021. Epub 2014 Jan 22.

PMID:
24462523
4.

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.

Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group.

J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.

5.

A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.

Yu CM, Zhang Q, Fung JW, Chan HC, Chan YS, Yip GW, Kong SL, Lin H, Zhang Y, Sanderson JE.

J Am Coll Cardiol. 2005 Mar 1;45(5):677-84.

6.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

7.

Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.

De Maria E, Gallo P, Damiano M, Scognamiglio G, De Simone C, Nilo S, Guarini P, Mascioli G, Curnis A.

Ital Heart J. 2005 Sep;6(9):734-9.

PMID:
16212075
8.

Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.

Vatankulu MA, Goktekin O, Kaya MG, Ayhan S, Kucukdurmaz Z, Sutton R, Henein M.

Am J Cardiol. 2009 May 1;103(9):1280-4. doi: 10.1016/j.amjcard.2009.01.023.

PMID:
19406272
9.

Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?

Yu CM, Zhang Q, Yip GW, Chan YS, Lee PW, Wu LW, Lam YY, Kum LC, Chan HC, Chan S, Fung JW.

Am J Cardiol. 2006 Oct 15;98(8):1083-7. Epub 2006 Aug 30.

PMID:
17027576
10.

Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.

Rickard J, Bassiouny M, Cronin EM, Martin DO, Varma N, Niebauer MJ, Tchou PJ, Tang WH, Wilkoff BL.

Am J Cardiol. 2011 Dec 1;108(11):1576-80. doi: 10.1016/j.amjcard.2011.07.017. Epub 2011 Sep 3.

PMID:
21890086
11.

Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors.

Gasparini M, Regoli F, Ceriotti C, Galimberti P, Bragato R, De Vita S, Pini D, Andreuzzi B, Mangiavacchi M, Klersy C.

Am Heart J. 2008 Mar;155(3):507-14. doi: 10.1016/j.ahj.2007.10.028. Epub 2007 Dec 19.

PMID:
18294488
12.

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40.

13.

Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.

Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB.

J Med Assoc Thai. 2007 Jul;90(7):1458-66.

PMID:
17710992
14.

Cardiac resynchronization therapy in patients with chronic heart failure: pathophysiology and current experience.

Seidl K, Rameken M, Vater M, Senges J.

Am J Cardiovasc Drugs. 2002;2(4):219-26. Review.

PMID:
14727967
15.

Left ventricular lead placement in cardiac resynchronization therapy: where and how?

Khan FZ, Virdee MS, Fynn SP, Dutka DP.

Europace. 2009 May;11(5):554-61. doi: 10.1093/europace/eup076. Epub 2009 Apr 16. Review.

PMID:
19372115
16.

Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.

Gold MR, Thébault C, Linde C, Abraham WT, Gerritse B, Ghio S, St John Sutton M, Daubert JC.

Circulation. 2012 Aug 14;126(7):822-9. doi: 10.1161/CIRCULATIONAHA.112.097709. Epub 2012 Jul 10.

17.

Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.

Porciani MC, Macioce R, Demarchi G, Chiostri M, Musilli N, Cappelli F, Lilli A, Ricciardi G, Padeletti L.

Eur J Echocardiogr. 2006 Jan;7(1):31-9.

PMID:
16378918
18.

A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure.

Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, Clémenty J, Boulogne E, Daubert JC; TRIP-HF (Triple Resynchronization In Paced Heart Failure Patients) Study Group.

J Am Coll Cardiol. 2008 Apr 15;51(15):1455-62. doi: 10.1016/j.jacc.2007.11.074.

19.
20.

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.

Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group.

Circulation. 2004 Nov 2;110(18):2864-8. Epub 2004 Oct 25.

Supplemental Content

Support Center